Zoetis (ZTS) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Zoetis · Health Care · ref. ETF XLV · 50 calls · price $74.3
What the company does: Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
📈 Zoetis (ZTS) stock price
$74.3-48.2% over range
Oct 14, 25low $69.1 · high $147.53Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 12 analysts
📊 JPI status : Zoetis has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ZTS price target & analyst consensus — price $74.30
The price target · all analysts combined (10 targets)
Highest target · 1 firm of 10$115+54.8%
Median target · of 10 targets$94.5+27.2%
Lowest target · 3 firms of 10$80+7.7%
Current price$74.3
Where these 10 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
10100%
$80 ↔ $115
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (830 calls tested). It aims for $99 (+33 %), call made on July 23, 2026, maturing on July 23, 2027 (83 d ago).
The 7 reliable analysts
$94+27 %
The 3 other firms
$95+28 %
How to read it: the 7 reliable firms are not filtered by optimism — 7 aim above the price, 0 below, hence their $94 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 12 ratings (last 6 months)
Strong Buy00%
Buy650%
Hold650%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ZTS price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on ZTS most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ZTS? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Zoetis? The JPI assistant answers using our backtest data.
💰 Zoetis dividend: yield, history & growth › open the full page
2.84%annual yield
📈 Steady dividend — 12 yrs of consecutive dividend increases
That's ~$2.06 per share per year.
📈 Zoetis fundamentals: valuation, margins & growth › open the full page
P/E 12.2Net margin 27.7 %Revenue growth -0.2 %Low P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 26 %
2023
Rev +6%Profit +11%
2024
Rev +8%Profit +6%
2025
Rev +2%Profit +8%
🏛️ Zoetis insider buying: who's buying and how much › open the full page
3 insiders bought3 buys / 6 mo $886k👥 Cluster buy
🔎 Detailed analyses
🏛️ Which US Congress members hold Zoetis (ZTS)?
9 Congress members have disclosed ZTS buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Daniel Goldman 3× · 25%Zoe Lofgren 2× · 41%John Curtis 2× · 62%Joe Courtney 1× · 40%Alan Lowenthal 1× · 35%Dan Newhouse 1× · 33%Robert Wittman 1× · 47%Greg Stanton 1× · 48%Rick Larsen 1×
✅ Historical analyst reliability on ZTS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| William Blair ↗ | 100% | +29.5% | 2 |
| BMO Capital ↗ | 100% | +16.0% | 6 |
| Atlantic Equities | 100% | +10.8% | 3 |
| Credit Suisse | 80% | +13.2% | 5 |
| Jefferies ↗ | 79% | +19.8% | 14 |
| JP Morgan ↗ | 71% | +14.6% | 7 |
| B of A Securities ↗ | 70% | +7.2% | 10 |
| Deutsche Bank ↗ | 67% | +20.2% | 3 |
| Citigroup ↗ | 67% | +2.5% | 3 |
| CL King | 50% | +10.3% | 2 |
See the other 9 firms
| BTIG ↗ | 0% | -17.5% | 2 |
| HSBC ↗ | 0% | -2.7% | 2 |
| Piper Sandler ↗ | 8% | -17.6% | 12 |
| Goldman Sachs ↗ | 38% | -6.0% | 8 |
| Morgan Stanley ↗ | 43% | -9.8% | 7 |
| Stifel ↗ | 43% | -0.3% | 21 |
| Barclays ↗ | 46% | -0.5% | 13 |
| Argus Research ↗ | 50% | -2.4% | 6 |
| Raymond James ↗ | 50% | +9.7% | 2 |
📊 What $1,000 invested in Zoetis would be worth › open the full page
In short — $1,000 invested in Zoetis 10 years ago would be worth $1,500 today, i.e. +4%/yr on average. Best year: 2019 (+55%), worst: 2022 (-40%). Price performance, excluding dividends.
If I'd invested $1,000 in Zoetis
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $441 | -56% |
| 3 years ago | $490 | -51% |
| 5 years ago | $434 | -57% |
Return by year (Zoetis)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -43% | $571 (-43%) |
| 2025 | -23% | $441 (-56%) |
| 2024 | -17% | $364 (-64%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Zoetis
Loading news…
📋 All analyst calls on ZTS
Filtered on — · ✕ show all
▲ Buy · 🎯$94
Price at call : $77.52 — upside +21%
Today : $74.3 — upside +27%
🎯 on ZTS : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Aug 25, 27
matures : Aug 25, 27
■ Hold neutral · not a buy · 🎯$80
Price at call : $75.02 — gap to target +7%
Today : $74.3 — gap to target +8%
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Aug 20, 27
matures : Aug 20, 27
▲ Buy · 🎯$96
Price at call : $73.54 — upside +31%
Today : $74.3 — upside +29%
🎯 on ZTS : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
BNP Paribas
Aug 11, 26
▲ Outperform · 🎯$110
Price at call : $73.54 — upside +50%
Today : $74.3 — upside +48%
🎯 on ZTS : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
Piper Sandler ↗
Aug 10, 26
■ Neutral neutral · not a buy · 🎯$80
Price at call : $75.35 — gap to target +6%
Today : $74.3 — gap to target +8%
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
■ Neutral neutral · not a buy · 🎯$80
Price at call : $74.83 — gap to target +7%
Today : $74.3 — gap to target +8%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Aug 8, 27
matures : Aug 8, 27
▲ Overweight · 🎯$115
Price at call : $74.83 — upside +54%
Today : $74.3 — upside +55%
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
William Blair ↗
Aug 6, 26
■ Market Perform neutral · not a buy
🎯 on ZTS : no call matured yet · 📊 on Health : 64.3% · +7.1% (28 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
See the other 42 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$85
Price at call : $77.51 — gap to target +10%
Today : $74.3 — gap to target +14%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Morgan Stanley ↗
Jul 22, 26
▲ Overweight · 🎯$99
Price at call : $74.57 — upside +33%
Today : $74.3 — upside +33%
🎯 on ZTS : 0% (2 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
▲ Buy · 🎯$95
Price at call : $76.29 — upside +25%
Today : $74.3 — upside +28%
🎯 on ZTS : no call matured yet · 📊 on Health : 55.2% · +1.7% (29 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
■ Equal-Weight neutral · not a buy · 🎯$85
Price at call : $72.45 — gap to target +17%
Today : $74.3 — gap to target +14%
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
▲ Buy · 🎯$104
Price at call : $72.45 — upside +44%
Today : $74.3 — upside +40%
🎯 on ZTS : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jun 30, 27
matures : Jun 30, 27
■ Hold neutral · not a buy · 🎯$85
Price at call : $73.25 — gap to target +16%
Today : $74.3 — gap to target +14%
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jun 26, 27
matures : Jun 26, 27
Argus Research ↗
May 27, 26
■ Hold neutral · not a buy
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : May 27, 27
matures : May 27, 27
■ Hold neutral · not a buy · 🎯$95
Price at call : $81.32 — gap to target +17%
Today : $74.3 — gap to target +28%
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
▲ Buy · 🎯$112
Price at call : $78.92 — upside +42%
Today : $74.3 — upside +51%
🎯 on ZTS : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
■ Neutral neutral · not a buy · 🎯$99
Price at call : $76.67 — gap to target +29%
Today : $74.3 — gap to target +33%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : May 9, 27
matures : May 9, 27
▲ Overweight · 🎯$130
Price at call : $76.67 — upside +70%
Today : $74.3 — upside +75%
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
■ Neutral neutral · not a buy · 🎯$130
Price at call : $113.83 — gap to target +14%
Today : $74.3 — gap to target +75%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
▲ Buy · 🎯$145
Price at call : $119.04 — upside +22%
Today : $74.3 — upside +95%
🎯 on ZTS : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
B of A Securities ↗
Feb 13, 26
■ Neutral neutral · not a buy · 🎯$140
Price at call : $126.65 — gap to target +11%
Today : $74.3 — gap to target +88%
🎯 on ZTS : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
Piper Sandler ↗
Jan 22, 26
■ Neutral neutral · not a buy · 🎯$135
Price at call : $124.4 — gap to target +9%
Today : $74.3 — gap to target +82%
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
■ Equal-Weight neutral · not a buy · 🎯$136
Price at call : $118.07 — gap to target +15%
Today : $74.3 — gap to target +83%
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▲ Buy · 🎯$160
Price at call : $122.57 — upside +31%
Today : $74.3 — upside +115%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
■ Sector Weight neutral · not a buy
🎯 on ZTS : no call matured yet · 📊 on Health : 43.4% · -1.8% (145 calls)
in progress (365j)
matures : Nov 21, 26
matures : Nov 21, 26
■ Hold neutral · not a buy · 🎯$130
Price at call : $118.14 — gap to target +10%
Today : $74.3 — gap to target +75%
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
▲ Buy · 🎯$160
Price at call : $121.25 — upside +32%
Today : $74.3 — upside +115%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
Morgan Stanley ↗
Nov 10, 25
▲ Overweight · 🎯$175
Price at call : $120.12 — upside +46%
Today : $74.3 — upside +136%
🎯 on ZTS : 0% (2 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
■ Neutral neutral · not a buy · 🎯$141
Price at call : $119.56 — gap to target +18%
Today : $74.3 — gap to target +90%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Overweight · 🎯$200
Price at call : $119.56 — upside +67%
Today : $74.3 — upside +169%
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
■ Neutral neutral · not a buy · 🎯$158
Price at call : $146.09 — gap to target +8%
Today : $74.3 — gap to target +113%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 21, 26
matures : Oct 21, 26
Argus Research ↗
Sep 9, 25
▲ Buy · 🎯$190
Price at call : $149.79 — upside +27%
Today : $74.3 — upside +156%
Expected +27% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 55.3% · +2.1% (159 calls)
-51.1%
stock -51% · XLV +20%
matured Sep 9, 26
Piper Sandler ↗
Aug 11, 25
▲ Overweight · 🎯$215
Price at call : $149.02 — upside +44%
Today : $74.3 — upside +189%
Expected +44% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-49.4%
stock -49% · XLV +29%
matured Aug 11, 26
Leerink Partners ↗
Jul 17, 25
■ Market Perform neutral · not a buy · 🎯$155
Price at call : $150.03 — gap to target +3%
Today : $74.3 — gap to target +109%
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : Jul 17, 26
matures : Jul 17, 26
■ Hold neutral · not a buy · 🎯$160
Price at call : $157.17 — gap to target +2%
Today : $74.3 — gap to target +115%
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jun 18, 26
matures : Jun 18, 26
Piper Sandler ↗
May 12, 25
▲ Overweight · 🎯$210
Price at call : $160.41 — upside +31%
Today : $74.3 — upside +183%
Expected +31% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-53.7%
stock -54% · XLV +11%
matured May 12, 26
■ Neutral neutral · not a buy · 🎯$170
Price at call : $161.69 — gap to target +5%
Today : $74.3 — gap to target +129%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : May 7, 26
matures : May 7, 26
▲ Buy · 🎯$165
Price at call : $149.22 — upside +11%
Today : $74.3 — upside +122%
Expected +11% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
-19.1%
stock -19% · XLV +7%
matured Apr 14, 26
Piper Sandler ↗
Feb 27, 25
▲ Overweight · 🎯$205
Price at call : $164.98 — upside +24%
Today : $74.3 — upside +176%
Expected +24% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-20.5%
stock -21% · XLV +9%
matured Feb 27, 26
▲ Overweight · 🎯$244
Price at call : $156.48 — upside +56%
Today : $74.3 — upside +228%
Expected +56% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
-19.8%
stock -20% · XLV +9%
matured Feb 14, 26
Morgan Stanley ↗
Feb 14, 25
▲ Overweight · 🎯$238
Price at call : $156.48 — upside +52%
Today : $74.3 — upside +220%
Expected +52% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (2 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
-19.8%
stock -20% · XLV +9%
matured Feb 14, 26
Piper Sandler ↗
Feb 10, 25
▲ Overweight · 🎯$200
Price at call : $174.29 — upside +15%
Today : $74.3 — upside +169%
Expected +15% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-26.2%
stock -26% · XLV +7%
matured Feb 10, 26
Morgan Stanley ↗
Jan 29, 25
▲ Overweight · 🎯$243
Price at call : $172.71 — upside +41%
Today : $74.3 — upside +227%
Expected +41% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (2 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
-27.7%
stock -28% · XLV +5%
matured Jan 29, 26
▲ Buy · 🎯$180
Price at call : $165.02 — upside +9%
Today : $74.3 — upside +142%
Expected +9% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
-23.1%
stock -23% · XLV +13%
matured Jan 7, 26
■ Neutral neutral · not a buy · 🎯$196
Price at call : $176.71 — gap to target +11%
Today : $74.3 — gap to target +164%
🎯 on ZTS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Dec 10, 25
matures : Dec 10, 25
Leerink Partners ↗
Dec 2, 24
▲ Outperform · 🎯$215
Price at call : $176.81 — upside +22%
Today : $74.3 — upside +189%
Expected +22% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 53.7% · -6.2% (41 calls)
-29.6%
stock -30% · XLV +5%
matured Dec 2, 25
▲ Overweight · 🎯$230
Price at call : $192.65 — upside +19%
Today : $74.3 — upside +210%
Expected +19% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
-26.2%
stock -26% · XLV -8%
matured Oct 11, 25
▲ Buy · 🎯$210
Price at call : $196.48 — upside +7%
Today : $74.3 — upside +183%
Expected +7% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on ZTS : 0% (4 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
-25.1%
stock -25% · XLV -12%
matured Sep 18, 25
Frequently asked questions
Should I buy Zoetis stock?
This isn't buy advice. For Zoetis, the analyst consensus is "Buy", with an average price target of $94.50 (+27% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Zoetis). We show the numbers — you decide.
Is it too late to buy Zoetis? How high can it go?
The most bullish analyst target on Zoetis is $115 (+55% above today's price); the average is $94.50. That's the upside they see. Check how reliable those analysts have actually been on Zoetis on our site before trusting it.
Is Zoetis still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 19 analysts have a real record on Zoetis, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Will Zoetis stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will ZTS stock recover (go back up)?
Should you invest in Zoetis? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ZTS (and why hesitate).
What has Zoetis's past performance been?
Historical returns and a "how much if I had invested" calculator: ZTS performance & returns.
Does Zoetis pay a dividend?
Yield, consistency and growth history of the dividend: ZTS's dividend.
Are insiders buying ZTS stock?
Executives' and large holders' buys and sells, decoded: insider buying on ZTS.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX